 | • レポートコード：QFJ1-4087 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、サイクロスポーラ診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗酸菌染色、サフラニン染色）、用途別市場規模（商業/私立研究所、病院、公衆衛生研究所、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・サイクロスポーラ診断検査の市場動向 ・企業の競争状況、市場シェア ・サイクロスポーラ診断検査の種類別市場規模と予測2016-2027（抗酸菌染色、サフラニン染色） ・サイクロスポーラ診断検査の用途別市場規模と予測2016-2027（商業/私立研究所、病院、公衆衛生研究所、診療所） ・サイクロスポーラ診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・サイクロスポーラ診断検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・サイクロスポーラ診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・サイクロスポーラ診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・サイクロスポーラ診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Beckman Coulter, Inc、bioMerieux, Inc.、CEPHEID、Diamedix Corporation、Hologic, Inc、Nanogen, Inc.、Ortho Clinical Diagnostics (a Johnson & Johnson company)、DiaSorin S.p.A.、Roche Diagnostics (a division of Hoffmann-La Roche)、Siemens Healthcare、QIAGEN N.V.、Wako Chemicals USA, Inc.） ・結論 |
Cyclospora cayetanensis, a single-celled coccidian parasitic pathogen, causes intestinal infection resulting in diarrhea. In medical terminology, this diarrheal infection is referred as cyclospora infection (cyclosporiasis).
Market Analysis and Insights: Global Cyclospora Diagnostic Testing Market
The global Cyclospora Diagnostic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cyclospora Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cyclospora Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cyclospora Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cyclospora Diagnostic Testing market.
Global Cyclospora Diagnostic Testing Scope and Market Size
Cyclospora Diagnostic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cyclospora Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Acid-fast Staining
Safranin Staining
Segment by Application
Commercial or Private Laboratories
Hospitals
Public Health Labs
Physician Offices
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Beckman Coulter, Inc
bioMerieux, Inc.
CEPHEID
Diamedix Corporation
Hologic, Inc
Nanogen, Inc.
Ortho Clinical Diagnostics (a Johnson & Johnson company)
DiaSorin S.p.A.
Roche Diagnostics (a division of Hoffmann-La Roche)
Siemens Healthcare
QIAGEN N.V.
Wako Chemicals USA, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cyclospora Diagnostic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acid-fast Staining
1.2.3 Safranin Staining
1.3 Market by Application
1.3.1 Global Cyclospora Diagnostic Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Commercial or Private Laboratories
1.3.3 Hospitals
1.3.4 Public Health Labs
1.3.5 Physician Offices
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cyclospora Diagnostic Testing Market Perspective (2016-2027)
2.2 Cyclospora Diagnostic Testing Growth Trends by Regions
2.2.1 Cyclospora Diagnostic Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cyclospora Diagnostic Testing Historic Market Share by Regions (2016-2021)
2.2.3 Cyclospora Diagnostic Testing Forecasted Market Size by Regions (2022-2027)
2.3 Cyclospora Diagnostic Testing Industry Dynamic
2.3.1 Cyclospora Diagnostic Testing Market Trends
2.3.2 Cyclospora Diagnostic Testing Market Drivers
2.3.3 Cyclospora Diagnostic Testing Market Challenges
2.3.4 Cyclospora Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cyclospora Diagnostic Testing Players by Revenue
3.1.1 Global Top Cyclospora Diagnostic Testing Players by Revenue (2016-2021)
3.1.2 Global Cyclospora Diagnostic Testing Revenue Market Share by Players (2016-2021)
3.2 Global Cyclospora Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cyclospora Diagnostic Testing Revenue
3.4 Global Cyclospora Diagnostic Testing Market Concentration Ratio
3.4.1 Global Cyclospora Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cyclospora Diagnostic Testing Revenue in 2020
3.5 Cyclospora Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Cyclospora Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Cyclospora Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cyclospora Diagnostic Testing Breakdown Data by Type
4.1 Global Cyclospora Diagnostic Testing Historic Market Size by Type (2016-2021)
4.2 Global Cyclospora Diagnostic Testing Forecasted Market Size by Type (2022-2027)
5 Cyclospora Diagnostic Testing Breakdown Data by Application
5.1 Global Cyclospora Diagnostic Testing Historic Market Size by Application (2016-2021)
5.2 Global Cyclospora Diagnostic Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cyclospora Diagnostic Testing Market Size (2016-2027)
6.2 North America Cyclospora Diagnostic Testing Market Size by Type
6.2.1 North America Cyclospora Diagnostic Testing Market Size by Type (2016-2021)
6.2.2 North America Cyclospora Diagnostic Testing Market Size by Type (2022-2027)
6.2.3 North America Cyclospora Diagnostic Testing Market Size by Type (2016-2027)
6.3 North America Cyclospora Diagnostic Testing Market Size by Application
6.3.1 North America Cyclospora Diagnostic Testing Market Size by Application (2016-2021)
6.3.2 North America Cyclospora Diagnostic Testing Market Size by Application (2022-2027)
6.3.3 North America Cyclospora Diagnostic Testing Market Size by Application (2016-2027)
6.4 North America Cyclospora Diagnostic Testing Market Size by Country
6.4.1 North America Cyclospora Diagnostic Testing Market Size by Country (2016-2021)
6.4.2 North America Cyclospora Diagnostic Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cyclospora Diagnostic Testing Market Size (2016-2027)
7.2 Europe Cyclospora Diagnostic Testing Market Size by Type
7.2.1 Europe Cyclospora Diagnostic Testing Market Size by Type (2016-2021)
7.2.2 Europe Cyclospora Diagnostic Testing Market Size by Type (2022-2027)
7.2.3 Europe Cyclospora Diagnostic Testing Market Size by Type (2016-2027)
7.3 Europe Cyclospora Diagnostic Testing Market Size by Application
7.3.1 Europe Cyclospora Diagnostic Testing Market Size by Application (2016-2021)
7.3.2 Europe Cyclospora Diagnostic Testing Market Size by Application (2022-2027)
7.3.3 Europe Cyclospora Diagnostic Testing Market Size by Application (2016-2027)
7.4 Europe Cyclospora Diagnostic Testing Market Size by Country
7.4.1 Europe Cyclospora Diagnostic Testing Market Size by Country (2016-2021)
7.4.2 Europe Cyclospora Diagnostic Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cyclospora Diagnostic Testing Market Size (2016-2027)
8.2 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Type
8.2.1 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Application
8.3.1 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Region
8.4.1 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cyclospora Diagnostic Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cyclospora Diagnostic Testing Market Size (2016-2027)
9.2 Latin America Cyclospora Diagnostic Testing Market Size by Type
9.2.1 Latin America Cyclospora Diagnostic Testing Market Size by Type (2016-2021)
9.2.2 Latin America Cyclospora Diagnostic Testing Market Size by Type (2022-2027)
9.2.3 Latin America Cyclospora Diagnostic Testing Market Size by Type (2016-2027)
9.3 Latin America Cyclospora Diagnostic Testing Market Size by Application
9.3.1 Latin America Cyclospora Diagnostic Testing Market Size by Application (2016-2021)
9.3.2 Latin America Cyclospora Diagnostic Testing Market Size by Application (2022-2027)
9.3.3 Latin America Cyclospora Diagnostic Testing Market Size by Application (2016-2027)
9.4 Latin America Cyclospora Diagnostic Testing Market Size by Country
9.4.1 Latin America Cyclospora Diagnostic Testing Market Size by Country (2016-2021)
9.4.2 Latin America Cyclospora Diagnostic Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cyclospora Diagnostic Testing Market Size (2016-2027)
10.2 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Type
10.2.1 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Application
10.3.1 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Country
10.4.1 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cyclospora Diagnostic Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Beckman Coulter, Inc
11.2.1 Beckman Coulter, Inc Company Details
11.2.2 Beckman Coulter, Inc Business Overview
11.2.3 Beckman Coulter, Inc Cyclospora Diagnostic Testing Introduction
11.2.4 Beckman Coulter, Inc Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.2.5 Beckman Coulter, Inc Recent Development
11.3 bioMerieux, Inc.
11.3.1 bioMerieux, Inc. Company Details
11.3.2 bioMerieux, Inc. Business Overview
11.3.3 bioMerieux, Inc. Cyclospora Diagnostic Testing Introduction
11.3.4 bioMerieux, Inc. Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.3.5 bioMerieux, Inc. Recent Development
11.4 CEPHEID
11.4.1 CEPHEID Company Details
11.4.2 CEPHEID Business Overview
11.4.3 CEPHEID Cyclospora Diagnostic Testing Introduction
11.4.4 CEPHEID Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.4.5 CEPHEID Recent Development
11.5 Diamedix Corporation
11.5.1 Diamedix Corporation Company Details
11.5.2 Diamedix Corporation Business Overview
11.5.3 Diamedix Corporation Cyclospora Diagnostic Testing Introduction
11.5.4 Diamedix Corporation Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.5.5 Diamedix Corporation Recent Development
11.6 Hologic, Inc
11.6.1 Hologic, Inc Company Details
11.6.2 Hologic, Inc Business Overview
11.6.3 Hologic, Inc Cyclospora Diagnostic Testing Introduction
11.6.4 Hologic, Inc Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.6.5 Hologic, Inc Recent Development
11.7 Nanogen, Inc.
11.7.1 Nanogen, Inc. Company Details
11.7.2 Nanogen, Inc. Business Overview
11.7.3 Nanogen, Inc. Cyclospora Diagnostic Testing Introduction
11.7.4 Nanogen, Inc. Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.7.5 Nanogen, Inc. Recent Development
11.8 Ortho Clinical Diagnostics (a Johnson & Johnson company)
11.8.1 Ortho Clinical Diagnostics (a Johnson & Johnson company) Company Details
11.8.2 Ortho Clinical Diagnostics (a Johnson & Johnson company) Business Overview
11.8.3 Ortho Clinical Diagnostics (a Johnson & Johnson company) Cyclospora Diagnostic Testing Introduction
11.8.4 Ortho Clinical Diagnostics (a Johnson & Johnson company) Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.8.5 Ortho Clinical Diagnostics (a Johnson & Johnson company) Recent Development
11.9 DiaSorin S.p.A.
11.9.1 DiaSorin S.p.A. Company Details
11.9.2 DiaSorin S.p.A. Business Overview
11.9.3 DiaSorin S.p.A. Cyclospora Diagnostic Testing Introduction
11.9.4 DiaSorin S.p.A. Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.9.5 DiaSorin S.p.A. Recent Development
11.10 Roche Diagnostics (a division of Hoffmann-La Roche)
11.10.1 Roche Diagnostics (a division of Hoffmann-La Roche) Company Details
11.10.2 Roche Diagnostics (a division of Hoffmann-La Roche) Business Overview
11.10.3 Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Introduction
11.10.4 Roche Diagnostics (a division of Hoffmann-La Roche) Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.10.5 Roche Diagnostics (a division of Hoffmann-La Roche) Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Details
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Cyclospora Diagnostic Testing Introduction
11.11.4 Siemens Healthcare Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.11.5 Siemens Healthcare Recent Development
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Details
11.12.2 QIAGEN N.V. Business Overview
11.12.3 QIAGEN N.V. Cyclospora Diagnostic Testing Introduction
11.12.4 QIAGEN N.V. Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.12.5 QIAGEN N.V. Recent Development
11.13 Wako Chemicals USA, Inc.
11.13.1 Wako Chemicals USA, Inc. Company Details
11.13.2 Wako Chemicals USA, Inc. Business Overview
11.13.3 Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Introduction
11.13.4 Wako Chemicals USA, Inc. Revenue in Cyclospora Diagnostic Testing Business (2016-2021)
11.13.5 Wako Chemicals USA, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cyclospora Diagnostic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acid-fast Staining
Table 3. Key Players of Safranin Staining
Table 4. Global Cyclospora Diagnostic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cyclospora Diagnostic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cyclospora Diagnostic Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cyclospora Diagnostic Testing Market Share by Regions (2016-2021)
Table 8. Global Cyclospora Diagnostic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cyclospora Diagnostic Testing Market Share by Regions (2022-2027)
Table 10. Cyclospora Diagnostic Testing Market Trends
Table 11. Cyclospora Diagnostic Testing Market Drivers
Table 12. Cyclospora Diagnostic Testing Market Challenges
Table 13. Cyclospora Diagnostic Testing Market Restraints
Table 14. Global Cyclospora Diagnostic Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cyclospora Diagnostic Testing Market Share by Players (2016-2021)
Table 16. Global Top Cyclospora Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclospora Diagnostic Testing as of 2020)
Table 17. Ranking of Global Top Cyclospora Diagnostic Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cyclospora Diagnostic Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cyclospora Diagnostic Testing Product Solution and Service
Table 21. Date of Enter into Cyclospora Diagnostic Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cyclospora Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cyclospora Diagnostic Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Cyclospora Diagnostic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cyclospora Diagnostic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cyclospora Diagnostic Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cyclospora Diagnostic Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Cyclospora Diagnostic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cyclospora Diagnostic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cyclospora Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cyclospora Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cyclospora Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cyclospora Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cyclospora Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cyclospora Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cyclospora Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cyclospora Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cyclospora Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cyclospora Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cyclospora Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cyclospora Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cyclospora Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cyclospora Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cyclospora Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cyclospora Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cyclospora Diagnostic Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cyclospora Diagnostic Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cyclospora Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cyclospora Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cyclospora Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cyclospora Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cyclospora Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cyclospora Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Cyclospora Diagnostic Testing Product
Table 64. Thermo Fisher Scientific Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Beckman Coulter, Inc Company Details
Table 67. Beckman Coulter, Inc Business Overview
Table 68. Beckman Coulter, Inc Cyclospora Diagnostic Testing Product
Table 69. Beckman Coulter, Inc Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 70. Beckman Coulter, Inc Recent Development
Table 71. bioMerieux, Inc. Company Details
Table 72. bioMerieux, Inc. Business Overview
Table 73. bioMerieux, Inc. Cyclospora Diagnostic Testing Product
Table 74. bioMerieux, Inc. Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 75. bioMerieux, Inc. Recent Development
Table 76. CEPHEID Company Details
Table 77. CEPHEID Business Overview
Table 78. CEPHEID Cyclospora Diagnostic Testing Product
Table 79. CEPHEID Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 80. CEPHEID Recent Development
Table 81. Diamedix Corporation Company Details
Table 82. Diamedix Corporation Business Overview
Table 83. Diamedix Corporation Cyclospora Diagnostic Testing Product
Table 84. Diamedix Corporation Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 85. Diamedix Corporation Recent Development
Table 86. Hologic, Inc Company Details
Table 87. Hologic, Inc Business Overview
Table 88. Hologic, Inc Cyclospora Diagnostic Testing Product
Table 89. Hologic, Inc Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 90. Hologic, Inc Recent Development
Table 91. Nanogen, Inc. Company Details
Table 92. Nanogen, Inc. Business Overview
Table 93. Nanogen, Inc. Cyclospora Diagnostic Testing Product
Table 94. Nanogen, Inc. Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 95. Nanogen, Inc. Recent Development
Table 96. Ortho Clinical Diagnostics (a Johnson & Johnson company) Company Details
Table 97. Ortho Clinical Diagnostics (a Johnson & Johnson company) Business Overview
Table 98. Ortho Clinical Diagnostics (a Johnson & Johnson company) Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 99. Ortho Clinical Diagnostics (a Johnson & Johnson company) Recent Development
Table 100. DiaSorin S.p.A. Company Details
Table 101. DiaSorin S.p.A. Business Overview
Table 102. DiaSorin S.p.A. Cyclospora Diagnostic Testing Product
Table 103. DiaSorin S.p.A. Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 104. DiaSorin S.p.A. Recent Development
Table 105. Roche Diagnostics (a division of Hoffmann-La Roche) Company Details
Table 106. Roche Diagnostics (a division of Hoffmann-La Roche) Business Overview
Table 107. Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Product
Table 108. Roche Diagnostics (a division of Hoffmann-La Roche) Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 109. Roche Diagnostics (a division of Hoffmann-La Roche) Recent Development
Table 110. Siemens Healthcare Company Details
Table 111. Siemens Healthcare Business Overview
Table 112. Siemens Healthcare Cyclospora Diagnostic Testing Product
Table 113. Siemens Healthcare Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 114. Siemens Healthcare Recent Development
Table 115. QIAGEN N.V. Company Details
Table 116. QIAGEN N.V. Business Overview
Table 117. QIAGEN N.V. Cyclospora Diagnostic Testing Product
Table 118. QIAGEN N.V. Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 119. QIAGEN N.V. Recent Development
Table 120. Wako Chemicals USA, Inc. Company Details
Table 121. Wako Chemicals USA, Inc. Business Overview
Table 122. Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Product
Table 123. Wako Chemicals USA, Inc. Revenue in Cyclospora Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 124. Wako Chemicals USA, Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cyclospora Diagnostic Testing Market Share by Type: 2020 VS 2027
Figure 2. Acid-fast Staining Features
Figure 3. Safranin Staining Features
Figure 4. Global Cyclospora Diagnostic Testing Market Share by Application: 2020 VS 2027
Figure 5. Commercial or Private Laboratories Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Public Health Labs Case Studies
Figure 8. Physician Offices Case Studies
Figure 9. Cyclospora Diagnostic Testing Report Years Considered
Figure 10. Global Cyclospora Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cyclospora Diagnostic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cyclospora Diagnostic Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Cyclospora Diagnostic Testing Market Share by Regions (2022-2027)
Figure 14. Global Cyclospora Diagnostic Testing Market Share by Players in 2020
Figure 15. Global Top Cyclospora Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclospora Diagnostic Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cyclospora Diagnostic Testing Revenue in 2020
Figure 17. Global Cyclospora Diagnostic Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Cyclospora Diagnostic Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cyclospora Diagnostic Testing Market Share by Type (2016-2027)
Figure 21. North America Cyclospora Diagnostic Testing Market Share by Application (2016-2027)
Figure 22. North America Cyclospora Diagnostic Testing Market Share by Country (2016-2027)
Figure 23. United States Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cyclospora Diagnostic Testing Market Share by Type (2016-2027)
Figure 27. Europe Cyclospora Diagnostic Testing Market Share by Application (2016-2027)
Figure 28. Europe Cyclospora Diagnostic Testing Market Share by Country (2016-2027)
Figure 29. Germany Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cyclospora Diagnostic Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cyclospora Diagnostic Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cyclospora Diagnostic Testing Market Share by Region (2016-2027)
Figure 39. China Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cyclospora Diagnostic Testing Market Share by Type (2016-2027)
Figure 47. Latin America Cyclospora Diagnostic Testing Market Share by Application (2016-2027)
Figure 48. Latin America Cyclospora Diagnostic Testing Market Share by Country (2016-2027)
Figure 49. Mexico Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cyclospora Diagnostic Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cyclospora Diagnostic Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cyclospora Diagnostic Testing Market Share by Country (2016-2027)
Figure 55. Turkey Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cyclospora Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 59. Beckman Coulter, Inc Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 60. bioMerieux, Inc. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 61. CEPHEID Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 62. Diamedix Corporation Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 63. Hologic, Inc Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 64. Nanogen, Inc. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 65. Ortho Clinical Diagnostics (a Johnson & Johnson company) Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 66. DiaSorin S.p.A. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 67. Roche Diagnostics (a division of Hoffmann-La Roche) Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 68. Siemens Healthcare Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 69. QIAGEN N.V. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 70. Wako Chemicals USA, Inc. Revenue Growth Rate in Cyclospora Diagnostic Testing Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界のクリプトスポリジウム症診断検査市場規模・現状・予測（2021年-2027年） Cryptosporidiosis is a diarrheal disease caused by microscopic parasites named “Cryptosporidium” that can live in intestine of humans and animals. These parasites are passed through the stool of an infected animal or person. Market Analysis and Insights: Global Cryptosporidium Diagnostic Testing Mar…- 世界のグラム染色システム市場規模・現状・予測（2021年-2027年） Gram staining is a screening test used to distinguish the bacterial species into gram positive and gram negative which would help in the diagnosis of different diseases. Over the years, manual staining process has been deployed in labs. However, recently there is development of automated staining sy…
- 世界のSTD診断検査市場規模・現状・予測（2021年-2027年） Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact. Market Analysis and Insights: Global Diagnostic Testing For STDs Market The global Diagnostic Testing For STDs market size is projected to reach US$ XX million by 2027, from US$ XX …
- 世界のトキソプラズマ症診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Toxoplasmosis Diagnostic Testing Market The global Toxoplasmosis Diagnostic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界のアレルギー診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allergy Diagnostic Testing Market The global Allergy Diagnostic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …